Polly Niravath

6PUBLICATIONS
48CO-AUTHORS
Women's studies (incl. girls' studies)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 30, 2026
VEMORA: Vaginal Estrogen versus non-hormonal MOisturizer in women Receiving Aromatase inhibitors: a randomized, controlled trial.

|Feb 09, 2026
A Phase II Study of Docetaxel and Pembrolizumab plus Interleukin 12 Gene Therapy in Nonmetastatic, Anthracycline-Refractory Triple-Negative Breast Cancer (INTEGRAL).

Polly Niravath, Ivonne Uzair, Kai Sun

|Oct 07, 2024
Characterization of the Breast Cancer Liver Metastasis Microenvironment via Machine Learning Analysis of the Primary Tumor Microenvironment.

Dylan A Goodin, Eric Chau, Junjun Zheng

|Jul 25, 2022
A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer.

Kai Sun, Yitian Xu, Licheng Zhang

|Dec 15, 2021
A phase 1/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancer.

Andrew W Chung, Kartik Anand, Ann C Anselme

|Feb 17, 2021
Measuring Ovarian Escape in Premenopausal Estrogen Receptor-Positive Breast Cancer Patients on Ovarian Suppression Therapy.

Ethan Burns, Emre Koca, Jiaqiong Xu

Pageof 1

Frequent Collaborators

3 joint publications

Jenny Chang

3 joint publications

Shu-Hsia Chen

3 joint publications

Yitian Xu

2 joint publications

Kai Sun